Bringing the Oncology Community Together

Dr. Sippel Explains Thyroid Cancer Risk Factors

Rebecca S. Sippel, MD
Published Online: Tuesday, October 2, 2012
Rebecca S. Sippel, MD, associate professor of surgery, University of Wisconsin, Madison, Wisconsin, explains that multiple studies have shown that the incidence and diagnosis of thyroid cancer is on the rise; however, the cause of this increase is largely unknown.

The major risk factors that call for added screening for thyroid cancer are radiation exposure and a positive family history. Unfortunately, the genetics of familial thyroid cancer are complicated and not well understood, Sippel believes. However, it is clear that every person with a first-degree relative that had thyroid cancer should be screened more aggressively.

Related Articles
FDA Panel Unanimously Recommends New DNA Stool Test
The FDA’s Molecular and Clinical Genetics advisory committee has unanimously supported the safety, efficacy, and positive risk-benefit profile of the noninvasive stool-based DNA test Cologuard in a 10-0 vote.
FDA Panel Narrowly Supports New CRC Blood Test
The blood-based colorectal cancer (CRC) screening test Epi proColon passed the scrutiny of the FDA’s Molecular and Clinical Genetics advisory panel in a close 5-4 vote with 1 abstention in support of the claim that the test’s benefits outweigh its risks
Continue Screening for PSA But Treat Judiciously
Screening for prostate-specific antigen (PSA) significantly cuts the death rate from prostate cancer, so America’s medical community should continue to offer the test to appropriate men, but at the same time should work harder to avoid the screen’s potential pitfalls.
Most Popular Right Now
More Reading
External Resources

American Journal of Managed Care
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
OncLive Resources

OncLive TV
Oncology Nurses
Web Exclusives

About Us
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.